Letters to the Editor

Pomalidomide, bortezomib and dexamethasone in multiple myeloma refractory to lenalidomide and anti-CD38 monoclonal antibodies: outcomes from a real-world experience

Department of Medicine and Aging Sciences, "G d'Annunzio" University, Chieti, Italy; Hematology Unit, Santo Spirito Hospital, Pescara
Unit of Biostatistics and Clinical Trial Center, Fondazione IRCCS Policlinico S. Matteo, Pavia
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seragnoli”, Bologna
AOU Policlinico G. Rodolico-San Marco, University School of Medicine, Catania
Hematology Unit, San Bortolo Hospital; Vicenza
Department of Hematology, Careggi Hospital and University of Florence
Department of Hematology, ASST Spedali Civili di Brescia; Brescia
Department of Hematology, GOM Niguarda Hospital, Milano
Department of Hematology, ASST Papa Giovanni XXIII, Bergamo
Department of Hematology, San Giovanni-Addolorata Hospital, Roma
Department of Onco-hematology, Hematology Unit, Azienda Ospedaliera Annunziata, Cosenza, Italy; Department of Pharmacy, Health and Nutritional Science, University of Calabria, Rende
Hematology and BMT Unit, Fondazione IRCCS Ospedale Maggiore Policlinico di Milano, University of Milan, Milano
Azienda USL - IRCCS di Reggio Emilia, Reggio Emilia
Department of Hematology and Transplantation, ASST di Monza, S Gerardo Hospital, Monza
S.C. Ematologia ASST Valle Olona Ospedale di Circolo Busto Arsizio
Azienda Ospedaliera San Camillo Forlanini, UOC Hematology and Stem Cell Transplant, Roma
Division of Hematology, Stem Cell Transplantation, Fondazione Policlinico Universitario Campus Bio Medico, Roma
Division of Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Universitaria Policlinico Umberto I di Roma, Sapienza University of Rome, Roma
Azienda Ospedaliero Universitaria S. Andrea, Roma
Clinica di Ematologia Azienda Ospedaliero Universitaria delle Marche, Ancona
Hematology and Stem Cell Transplantation Unit, AOUC Policlinico di Bari, Bari
Hematology and BMT Unit, IRCCS Ospedale San Raffaele, Milano
UOC Ematologia, Ospedale Civile di Legnano, Legnano
Department of Hematology, ASST Papa Giovanni XXIII, Bergamo
Faculty of Medicine and Surgery, "Kore" University of Enna, Enna
Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia
Hematology Unit, Santo Spirito Hospital, Pescara
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seragnoli”, Bologna, Italy; Dipartimento di Scienze Mediche e Chirurgiche, Universita di Bologna, Bologna
Department of Hematology, Careggi Hospital and University of Florence
Department of Hematology, GOM Niguarda Hospital, Milano
IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia “Seragnoli”, Bologna
Department of Hematology, ASST Spedali Civili di Brescia; Brescia
Division of Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Universitaria Policlinico Umberto I di Roma, Sapienza University of Rome, Roma
Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia
Clinica di Ematologia Azienda Ospedaliero Universitaria delle Marche, Ancona
Division of Hematology, Department of Translational and Precision Medicine, Azienda Ospedaliera Universitaria Policlinico Umberto I di Roma, Sapienza University of Rome, Roma
Division of Hematology, Fondazione IRCCS Policlinico San Matteo, Pavia
Haematologica Early view Mar 26, 2026 https://doi.org/10.3324/haematol.2025.289143